T lymphocytes in schizophrenia
Coffey, C.E.; Sullivan, J.L.; Rice, J.R.
Biological Psychiatry 18(1): 113-119
1983
ISSN/ISBN: 0006-3223 PMID: 6131701 Document Number: 215911
Document emailed within 1 workday
Related Documents
Bogdanova, E.D.; Domashneva, I.V.; Prilipko, L.L. 1978: Hemolytic properties of the lymphocytes of schizophrenia patients Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 78(1): 77-80Vereshchagina, G.V. 1973: The activity of lactate dehydrogenase and its isoenzymes in the lymphocytes of patients with schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 73(6): 871-877
Kurilova, I.I. 1971: RNA synthesis by schizophrenia patients lymphocytes in short living cultures Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 71(9): 1363-1367
Babaian, N.G.; Lideman, R.R.; Lozovskii, D.V.; Prilipko, L.L.; Faktor, M.I. 1978: Role of serum factors in decreasing the reaction of peripheral blood lymphocytes in schizophrenia to PHA stimulation Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 78(1): 80-86
Heinze, G.; King, G.B.; Huerto, L.; Ortega, H.; Cortés, J.; Ariza, J.R. 1994: The binding of 3H-spiperone to lymphocytes in patients with schizophrenia and first-degree relatives: in search of a genetic marker Gaceta Medica de Mexico 130(4): 241-245
Sakane, T.; Green, I. 1978: Protein a from Staphylococcus aureus-a mitogen for human T lymphocytes and B lymphocytes but not L lymphocytes Journal of Immunology 120(1): 302-311
Schooler, N.R.; Keith, S.J.; Severe, J.B.; Matthews, S. 1989: Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 331-335
Roxo, H. 1952: Pseudoneurotics; patients at the onset of schizophrenia; differential diagnosis of neurasthenia and schizophrenia; modern therapy Imprensa Medica 28(463): 25-30
Zaytseva, Y.; Burova, V.; Garakh, Z.; Gurovich, I.Y. 2013: Attributional style in fist episode of schizophrenia and schizophrenia spectrum disorders with and without paranoid ideation Psychiatria Danubina 25(Suppl 2): S329-S331
Kotlicka-Antczak, M.; Rabe-Jabłońska, J. 1997: Neurodevelopmental schizophrenia: the concept of developmental origins of certain forms of schizophrenia Psychiatria Polska 31(5): 527-538
Tsirkin, S.Iu. 1987: International study of schizophrenia based on a WHO program. Incidence of schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(8): 1203-1207
Hamajima, K.; Osono, M.; Kawamura, A. 1978: Augmented mitotic response of human peripheral lymphocytes in the presence of lymphocytes from nude mice: detection of a small number of functional human lymphocytes in the explanted host Japanese Journal of Experimental Medicine 48(3): 243-250
Arraras, J.I.; Basterra, I.; Pereda, N.; Ibañez, B.; Iribarren, S.; Cabases, J.M. 2019: The Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) questionnaire. A validation study with Spanish schizophrenia spectrum outpatients Actas Espanolas de Psiquiatria 47(3): 97-109
Suzuki, S. 1982: The mental maturation and verbal alteration in a mild case of chronic non-paranoiac schizophrenia. a linguistic-phenomenological approach to the concept of schizophrenia simplex Seishin Shinkeigaku Zasshi 84(1): 1-19
Hargreaves, W.A.; Kane, J.M.; Ninan, P.T.; Severe, J.B.; Woerner, M. 1989: Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 340-343
Williams, J.; Spurlock, G.; McGuffin, P.; Mallet, J.; Nöthen, M.M.; Gill, M.; Aschauer, H.; Nylander, P.O.; Macciardi, F.; Owen, M.J. 1996: Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group Lancet 347(9011): 1294-1296
Keefe, R.S.; Mohs, R.C.; Davidson, M.; Losonczy, M.F.; Silverman, J.M.; Lesser, J.C.; Horvath, T.B.; Davis, K.L. 1988: Kraepelinian schizophrenia: a subgroup of schizophrenia? Psychopharmacology Bulletin 24(1): 56-61
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347
Dadić-Hero, E.; Ruzić, K.; Palijan, T.Z.ć; Graovac, M.; Siuc-Valković, D.; Knez, R.; Grahovac, T. 2013: Relations between the course of illness, family history of schizophrenia and family functioning in persons with schizophrenia Collegium Antropologicum 37(1): 47-55
Nakayasu, N.; Seki, Y.; Harima, H. 1999: Age of onset, frequency of the development of symptoms, and treatment outcome in the early stage of schizophrenia--in search of guidelines for early diagnosis and treatment of schizophrenia Seishin Shinkeigaku Zasshi 101(11): 898-907